Clinical Trial Update: Efficacy and Safety of HRS-7535 Tablets in Adults With Diabetic Kidney Disease in Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial assessing efficacy and safety of HRS-7535 tablets in adults with diabetic kidney disease and type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• HRS-7535 (HRS-7535)

Snippet

Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Diabetic Kidney Disease, Type 2 Diabetes | Phase 2 | Status: COMPLETED